The international new drug R&D service platform project invested and constructed in the Lingang area of the Shanghai pilot covers an area of 8,000 square meters.
We adhere to the highest ethical and commercial standards, to create a high-tech biomedical enterprise with China's independent innovation, focusing on chemistry.
